Abstract |
Transforming growth factor type-e ( TGFe) is a novel TGF which was first described as a growth factor possibly involved in autocrine stimulation of anchorage-independent growth of carcinoma cells. Its later identification in normal tissues, plasma, and platelets suggested a role for TGFe in normal cell growth. This study shows that TGFe stimulates both anchorage-dependent and -independent growth of epithelial and fibroblastic cells of nonneoplastic origin. The mitogenic activity of TGFe in monolayer is slightly less than that of basic fibroblast growth factor, equipotent to that of epidermal growth factor, and greater than that of IGF-1. TGFe acts as a progression factor for both AKR-2B and Balb-3T3 cells. TGFe is also a potent mitogen for normal human epidermal keratinocytes and may therefore play a role in epidermal growth and regeneration.
|
Authors | C A Brown, J Halper |
Journal | Experimental cell research
(Exp Cell Res)
Vol. 190
Issue 2
Pg. 233-42
(Oct 1990)
ISSN: 0014-4827 [Print] United States |
PMID | 2209726
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Growth Substances
- Platelet-Derived Growth Factor
- transforming growth factor type e
- Tritium
- Fibroblast Growth Factor 2
- Epidermal Growth Factor
- Insulin-Like Growth Factor I
- Transforming Growth Factors
- DNA
- Thymidine
|
Topics |
- Animals
- Cell Adhesion
(drug effects)
- Cell Division
(drug effects)
- Cells, Cultured
- DNA
(biosynthesis)
- Embryo, Mammalian
(cytology, drug effects)
- Epidermal Growth Factor
(pharmacology)
- Epithelial Cells
- Epithelium
(drug effects)
- Fibroblast Growth Factor 2
(pharmacology)
- Fibroblasts
(cytology, drug effects)
- Growth Substances
(pharmacology)
- Insulin-Like Growth Factor I
(pharmacology)
- Keratinocytes
(cytology, drug effects)
- Mice
- Mice, Inbred BALB C
- Platelet-Derived Growth Factor
(pharmacology)
- Thymidine
(metabolism)
- Transforming Growth Factors
(pharmacology)
- Tritium
|